Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects

Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects

Abstract Diabetic retinopathy (DR) is the main cause of vision loss or blindness in working age adults worldwide. The lack of effective diagnostic biomarkers for DR leads to unsatisfactory curative treatments. To define potential metabolite biomarkers for DR diagnosis, a multiplatform‐based metabolo...

Full description

Bibliographic Details
Main Authors: Qiuhui Xuan, Yang Ouyang, Yanfeng Wang, Liang Wu, Huating Li, Yuanyuan Luo, Xinjie Zhao, Disheng Feng, Wangshu Qin, Chunxiu Hu, Lina Zhou, Xinyu Liu, Haidong Zou, Chun Cai, Jiarui Wu, Weiping Jia, Guowang Xu
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Advanced Science
Subjects:
diabetic retinopathy
lipidomics
metabolomics
multiplatforms
serum biomarkers
Online Access:https://doi.org/10.1002/advs.202001714

Internet

https://doi.org/10.1002/advs.202001714

Similar Items